Turning cold tumors hot: from molecular mechanisms to clinical applications
Cited by (544)
Items 301–400 of 544
- Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular CarcinomaChenhao Jiang, Zijian Liu, Jingsheng Yuan, Zhenru Wu, Lingxiang Kong, Jiayin Yang, Tao Lv · 2023 · International Journal of Molecular Sciences
- Mini-review: the distinct roles of STING signaling in tumor immunity—recent progressShengli Wang, Tao Li, Hongyan Sun, Danchun Chen, Hongbiao Xu, Jianlei Hao · 2023 · Journal of Leukocyte Biology
- Prognostic and immunotherapeutic implications of bilirubin metabolism‐associated genes in lung adenocarcinomaKangqi Ren, Xiean Ling, Chen Lin, Zeyao Li, Tonghai Huang · 2024 · Journal of Cellular and Molecular Medicine
- Prognostic Value and Immune Signatures of Anoikis-related Genes in Breast CancerQing Wu, Luo Yang, Nan Lin, Shiyao Zheng, Xianhe Xie · 2024 · Journal of Immunotherapy
- Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor ActivitySayumi Yamazoe, Yam B. Poudel, Emanuela I. Sega, Anandaroop Mukhopadhyay, Radha Ramakrishnan, Okechukwu T. Ukairo, Scot D. Liu, Rahima Akter, Keerthi Caroline Sadanala, Kathryn Que et al. · 2025 · Journal of Medicinal Chemistry
- A customized immunomodulator reinforces the T cell-mediated immunological cascade for cancer therapyGuowang Cheng, Jiaxin Wu, Wei Liu, Yumiao Yang, Hao Cui, Xiuxiu Dai, Bowen Li, Zhen Tian, Xiaojia Chen, Xiaohui Li et al. · 2025 · Chemical Engineering Journal
- RNA vaccines for cancer: revolutionizing immunization strategiesDi Huang, Jiahui Zhang, Xin Zeng, Yin Zhang, Erwei Song · 2025 · Trends in cancer
- Integrated pathway analysis identifies prognostically relevant subtypes of glioblastoma characterized by abnormalities in multi‐omicsPei Zhang, Dan Liu, Tonghui Yu, Yanlin Zhang, Lu Xing Zhong, Xiao Ouyang, Xia Qin, Lei Dong · 2025 · Clinical and Translational Medicine
- cGAS/STING-mediated γδ T cell recruitment drives radioresistance: implications for improving radioimmunotherapy outcomesBrooke C Braman, David Ronan Raleigh · 2025 · Journal of Clinical Investigation
- Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytesSimon A. Grassmann, Endi K. Santosa, Hyunu Kim, Isabelle B. Johnson, Adriana M. Mujal, Jean-Benoît Le Luduec, Sherry Fan, Mark Owyong, Adrian Straub, Liang Deng et al. · 2026 · Immunity
- AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapyKONG Qiqi, Yunqing Ban · 2026 · Frontiers in Oncology
- Targeting cytokine/chemokine signaling to convert immunologically cold tumors into hot: Emerging strategies in cancer immunotherapyJung Hee Park, Dae Ui Lee, Jongbin Jeong, Kyung Hee Jung, Soon‐Sun Hong · 2026 · Acta Pharmaceutica Sinica B
- Microvascular and stromal normalization combined with nano-immunotherapy: A synergistic strategy to overcome drug delivery barriers in solid tumorsFatemeh Mirala, Farshad Moradi Kashkooli, M. Soltani · 2026 · Microvascular Research
- Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological MalignanciesSevgi Gezici · 2023 · Elsevier eBooks
- Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosisYongfeng Wang, Yanzong Zhao, Guangming Zhang, Yifeng Lin, Chunling Fan, Hui Wei, Shude Chen, Ling Guan, Kan Liu, Sixian Yu et al. · 2024 · Scientific Reports
- Effect of cryoablation on the spatial transcriptomic landscape of the immune microenvironment in non-small cell lung cancerJun Zhou, Shengxi Wang, Ming Liu, Zhaopei Li · 2024 · Journal of Cancer Research and Therapeutics
- Functional Materials Targeted Regulation of Gasdermins: From Fundamentals to Functionalities and ApplicationsLuyao Tian, Shuo Piao, Xia Li, Lanping Guo, Luqi Huang, Wenyuan Gao · 2025 · Advanced Science
- Targeting DKK3 to remodel tumor immune microenvironment and enhance cancer immunotherapyKai Shi, Yan Zhao, Hao Ye, Xiaoming Zhu, Zhenghai Chen · 2025 · BMC Cancer
- Nuclear glycine decarboxylase suppresses STAT1-dependent MHC-I and promotes cancer immune evasionRui Liu, Hui-Fang Li, Qi Jiang, Jun-Ge Shi, Zi-Lun Ruan, Peng Ren, Yinuo Li, Hong‐Bing Shu, Shu Li · 2025 · The EMBO Journal
- A pan-cancer analysis revealed SKP2 as an inhibitor of the tumor immune microenvironment and a promising therapeutic target for immunotherapyXingyu Liao, Yaxin Zhang, Xue Qing Yu, Wei Du, Linxi Chen, Zhiqing Zhao, Haijie Liang, Xingyu Liu, Feiyang Qi, David S Geller et al. · 2025 · Precision Clinical Medicine
- In vivo visualization of immunosuppressive cells in the tumor microenvironmentGuangfa Bao, Jianyuan Zhou, Siyuan Cheng, Jun Zhao, Xiaohua Zhu · 2023 · iRadiology
- Prognostic and therapeutic insights into colorectal carcinoma through immunogenic cell death gene profilingJing-Lu Yu, Yabin Gong, Zhenye Xu, Lei Chen, Shuang Li, Yongkang Cui · 2024 · PeerJ
- Pan-cancer analysis of Sp1 with a focus on immunomodulatory roles in gastric cancerYang Zhou, Zhenzhen Luo, Jinfeng Guo, Lixia Wu, Xiaoli Zhou, Jun Jie Huang, Daijia Huang, Xiao Li, Qiuhua Duan, Jianhua Chang et al. · 2024 · Cancer Cell International
- Bortezomib induces cell apoptosis and increases the efficacy of αPD-1 in BCR::ABL T315I mutation CML by targeting UBE2Q1Fengyu Jiang, Wenjie Liu, Yanyu Zhou, Siwei Lin, Qin Zhang, Wan Zhang, Yangyang Xue, Chao Li, Anran Gao, Miaomiao Shao et al. · 2024 · International Immunopharmacology
- Control of aggressive 4T1-luc metastatic breast cancer using immunogenic cell lysates generated with methotrexateLuana Cristina Camargo, Pedro Burgel, Camila Magalhães Cardador, Victor Carlos Mello da Silva, Karen L. R. Paiva, Marina Mesquita Simões, Raffael Júnio Araújo de Castro, Isabel Martinello Valente, Gabriel Ribeiro Farias, Thais Bergmann de Castro et al. · 2025 · Biomedicine & Pharmacotherapy
- Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancerQing Wu, Shiyao Zheng, Nan Lin, Xianhe Xie · 2023 · BMC Medical Genomics
- A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencingXu Chen, Chuang Peng, Yu Chen, Bai Ding, Sulai Liu, Yinghui Song, Yuhang Li, Bo Sun, Ranzhiqiang Yang · 2023 · BMC Bioinformatics
- Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcomaValentina B. Stevenson, Erwin Kristobal Gudenschwager Basso, Shawna L. Klahn, Tanya LeRoith, William R. Huckle · 2023 · Veterinary and Comparative Oncology
- Integrative analysis of single-cell and bulk RNA-sequencing data revealed T cell marker genes based molecular sub-types and a prognostic signature in lung adenocarcinomaYue-Ling Peng, Yafang Dong, Qihui Sun, Yue Zhang, Xiangyang Zhou, Xiaoyang Li, Yuehong Ma, Xingwei Liu, Rongshan Li, Fengjie Guo et al. · 2024 · Scientific Reports
- Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and NanotechnologyZongchao Yu, Zhongcheng Mo, Yuan Qiu, Hengzhe Lu, Biao Zheng, Longfei Liu · 2024 · Current Pharmaceutical Biotechnology
- Pan‐cancer analysis of DCTN2 and its tumour‐promoting role in HCC by modulating the AKT pathwayShuning Xu, Jiyuan Xing, Ke Li, Lei Qiao, Cheng Zhang, Yulin Ren, Ying Liu · 2024 · Journal of Cellular and Molecular Medicine
- Necroptosis-related lncRNAs: establishment of a gene module and distinction between the cold and hot tumors in gliomaKangxi Cao, Fengbo Su, Xuchun Shan, Xingyu Jiang, Zhaohui Ni, Yan Chen · 2023 · Frontiers in Oncology
- Lymphocyte subsets and inflammatory factors as predictors of immunotherapy efficacy in patients with hepatocellular carcinomaGao Shuyue, Jiamin Cheng, Niansong Qian · 2023 · Scientific Reports
- Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axisDaciana Catalina Dumut, Marián Hajdúch, Amanda M Zacharias, Qingling Duan, Ivo Frydrych, Zuzana Rozankova, Miroslav Popper, Dušan Garić, Radu Alexandru Paun, Amanda Centorame et al. · 2025 · Frontiers in Immunology
- Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated ChemotherapyPengfei Yuan, Tianci Zhu, Xiaodie Yan, Wen Liu, Lamei Liu, Xiaoqing Zong, Caiqi Yang, Xinjie Chen, Siying Wei, Yaoqi Wen et al. · 2025 · ACS Applied Materials & Interfaces
- Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder CancerZongjian Liang, Yu An, Jie He, Zhiqiang Zhu, Kehua Jiang, Kun Chen, Fa Sun · 2025 · International Journal of General Medicine
- Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in CancerPrakash Kulkarni, Sravani Keerthi Ramisetty, Débora S. Bruno, Tingting Tan, Amartej Merla, Ravi Salgia · 2025 · Cancer treatment and research
- Chinese medicines as therapeutic options for treating prostate cancer: Therapeutic effects and underlying mechanismsShenglong Li, Shuaishuai Jing, Jiuyun Zhou, Hui Li, Pengdong Yin, Qingwei zhang, Mei-Sheng Gong, Yongqiang Zhao, Gang-Gang Lu, Gi-Heang Jin et al. · 2025 · Journal of Ethnopharmacology
- Engineering a garlic-derived nanovesicle/microneedle system to boost melanoma immunotherapy through self-amplifying cell death activation and immune remodellingJing Li, Jie Wang, Bingqian Li, Meng Long, Xiumei Liu, Dengxuan Mao, Patrick Pan, Ying Liu, Zimei Wu, Yaqi Lyu et al. · 2025 · Chinese Chemical Letters
- Suppressing glutamine metabolism in the pancreatic cancer microenvironment can enhance the anti-tumor effect of CD8 T cells and promote the efficacy of immunotherapyJun Fan, Jianfei Chen, Rui Wang, Yisheng Peng, Sunde Tan, Xiaoli Zhang, Hao Tang, Maoshan Chen, Bo Li, Xiaoli Yang · 2025 · Frontiers in Immunology
- Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeuticsMichelle H. Teplensky, Julianna N. Bourgeois, Sergej Kudruk, Sarah Hurst Petrosko, Chad Alexander Mirkin · 2025 · Proceedings of the National Academy of Sciences
- Regulated necrosis at the crossroads of liver inflammation and cancer developmentMihael Vucur, Vangelis Kondylis, Petr Brož, Tom Luedde · 2025 · Nature Reviews Gastroenterology & Hepatology
- Demonstration of SLU7 as a new cancer targetCarla Rojo, Aaron Otero, María Elizalde, María Azkona, Roberto Barbero, Maria Ujue Latasa, Iker Uriarte, Álvaro Gutiérrez-Uzquiza, Diego Alignani, Laura Guembe et al. · 2025 · Biomedicine & Pharmacotherapy
- Low-intensity pulsed ultrasound (LIPUS)-augmented calcicoptosis by calcium-based nanoparticles for enhanced immunogenic cell death induction in triple-negative breast cancerYang Gao, Ziting Xu, Yingshan Gao, Li Zhang, Liang Yu, Qiuyu Li, Minyi Liu, Haibo Lan, Yanyan Zhang, Bingxia Zhao et al. · 2025 · Journal of Nanobiotechnology
- Metformin glycyrrhetinic acid binary injectable hydrogel for synergistic tumor immunotherapy via spatiotemporal microenvironment remodelingA. Ouyang, Xin Yu Qin, Bo Su, Shaojuan Mo, Jiujun Jiang, Zixin Wang, Yu Li, Jiayu Lu, Yangzheng Lin, Jie Wang et al. · 2025 · Materials Today Bio
- Tumor organoid-immune cell co-culture systems for precision oncologyLei Cai, Yunfeng Xiao, Feihong Xie, Zongke Yang · 2026 · Frontiers in Cell and Developmental Biology
- Landscape of unconventional γδ T cell subsets in cancerParviz Azimnasab-sorkhabi, Maryam Soltani-asl, Mohammad Soleiman Ekhtiyari, José Roberto Kfoury · 2024 · Molecular Biology Reports
- A biomimetic solution, albumin–doxorubicin molecular complex, targeting tumor and tumor-draining lymph nodesRui Guo, Lanlan Zhong, Si‐Rui Ma, Bokai Gong, Chen Shen, Zijun Wang, Li Deng, Dong Fu Zhao, Huile Gao, Tao Gong · 2024 · Journal of Materials Chemistry B
- Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironmentQuan Chen, Weijun Wan, Qing Zhao, Juan Li, Yanli Xiong, Yuchuan Yuan, Lu Tang, Xiaofeng Wu, Wei Xing, Wei Guo et al. · 2024 · Frontiers in Immunology
- Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of CancerKimberly D. Herman, Ian Holyer, Duncan C. Humphries, James A. Roper, Kristoffer Peterson, Fredrik R. Zetterberg, Anders Pedersen, Alison C. MacKinnon, Robert J. Slack · 2025 · Pharmacology
- Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and ToxicitySimeng Chen, Yuan Lin, Dan Li, Xiaoru Zhou, Xing Sun, Changyong Yang, Cheng Liao · 2025 · Molecular Cancer Therapeutics
- In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinomaUdit Basak, Sumon Mukherjee, Sourio Chakraborty, Gaurisankar Sa, Shubhra Ghosh Dastidar, Tanya Das · 2025 · Scientific Reports
- The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responsesHsuan‐Yu Peng, Yuli Huang, Ping‐Hsiu Wu, Lijie Li, Bou‐Yue Peng, Chia-Yu Wu, Yu‐Lung Lin, Michael Hsiao, Jang-Yang Chang, Peter Mu‐Hsin Chang et al. · 2025 · Cancer Cell International
- Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic GrowthSurajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, Zeribe C. Nwosu, Ke Xu, Elke van Beek, Priyanka Prakash Desai, Sivasish Sindiri, Sruthi Chempati, Kirsten Remmert et al. · 2025 · Cancer Discovery
- Local delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumorsDun Niu, Xiaozhuang Ma, Junshi Zhu, Liangbo Sun, Shaotong Zhang, Yaran Wu, Meihua Shan, Xufang Dai, Yaling Liao, Dong Liu et al. · 2025 · Cell Reports Medicine
- Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8Elias A. T. Koch, Renato Liguori, Alejandro Afonso Castro, Stefan Schliep, Anne Petzold, Anja Wessely, Waltraud Fröhlich, Fulvia Ferrazzi, Julio Vera, Markus Eckstein et al. · 2025 · International Journal of Molecular Sciences
- Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic predictionYutian Sun, Ming Yang, Qingyuan Zhang · 2022 · Annals of Translational Medicine
- Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticlesCarlos Martínez-Torró, Lorena Alba‐Castellón, Luis Miguel Carrasco-Díaz, Naroa Serna, Laura Imedio, Alberto Gallardo, Isolda Casanova, Ugutz Unzueta, Esther Vázquez, Ramón Mangues et al. · 2023 · Biomedicine & Pharmacotherapy
- DENDRITIC CELLS IN GLIOBLASTOMA TREATMENT: A MODERN VIEW OF THE PROBLEM AND OWN EXPERIENCEOleksandr Glavatskyi, N. Khranovska, O. Skachkova, Oleksandr I. Gorbach, Hennadii V. Khmelnytskyi, Irina Shuba, Pedachenko Eg, Oksana V. Zemskova, Oksana V. Zemskova · 2023 · Experimental Oncology
- The Tumor Microenvironment and Immune Response in Breast CancerBehjatolah Monzavi‐Karbassi, Thomas J. Kelly, Steven R. Post · 2024 · International Journal of Molecular Sciences
- Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical StudiesGere S. diZerega, Holly A. Maulhardt, Shelagh J. Verco, Alyson M. Marin, Michael Jay Baltezor, Samantha A. Mauro, Marc A. Iacobucci · 2024 · Oncology and Therapy
- Individual Survival Distributions Generated by Multi-Task Logistic Regression Yield a New Perspective on Molecular and Clinical Prognostic Factors in Gastric AdenocarcinomaDaniel Skubleny, Jennifer L. Spratlin, Sunita Ghosh, Russell Greiner, Dan Schiller, Gina R. Rayat · 2024 · Cancers
- Spatiotemporally Controlled T‐Cell Combination Therapy for Solid TumorMeixi Hao, Ying Zhou, Sijia Chen, Yu Jin, Xiuqi Li, Lingjing Xue, Mingxuan Shen, Weishuo Li, Can Zhang · 2024 · Advanced Science
- A hot and cold tumor‑related prognostic signature for stage II colorectal cancerMing Zhou, Xiaoxu Ge, Xiaoming Xu, Biao Sheng, Hao Wang, Haoyu Shi, Sikun Liu, Boren Tan, Kailun Xu, Jian Wang · 2024 · Oncology Letters
- A computational analysis of the oncogenic and anti-tumor immunity role of P4HA3 in human cancersHongyan Huang, Fu Wei Zhang, Jie Yu, Yan Hong Xiao, Di Zhu, Xiao-Lin Yi, Xiaohua Lin, Ming Li Jin, Hai Yun Jin, Yongsheng Huang et al. · 2024 · PLoS Computational Biology
- A Senescence-Associated Gene Signature for Prognostic Prediction and Therapeutic Targeting in Adrenocortical CarcinomaHangya Peng, Qiujing Chen, Lei Ye, Weiqing Wang · 2025 · Biomedicines
- The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional profilingBonan Chen, Wai Nok Chan, Fuda Xie, Chun Wai Mui, Alvin H.K. Cheung, Xiaoli liu, Raymond Wai Ming Lung, Chit Chow, Zhenhua Zhang, Shihua Shi et al. · 2023 · Research Square
- Transcriptomic analysis reveals potential crosstalk genes and immune relationship between triple-negative breast cancer and depressionZhili Zhuo, Wenping Lü, Ling Zhang, Dongni Zhang, Yongjia Cui, Xiaoqing Wu, Heting Mei, Lei Chang, Qingya Song · 2024 · Discover Oncology
- Bone Voyage: OPN's Path from Skeleton to Systemic ImmunosuppressionKyoko Hashimoto, Kazuo Okamoto, Hiroshi Takayanagi · 2025 · Cancer Research
- Targeted Inhibition of Tumor Extracellular Vesicle Secretion Improving the Anti‐Tumor Immunity of Lymph Node‐Targeted VaccinesFei Wang, Manqi Yan, Junming Dong, Xinyan Xie, Nan Zhang, Ting Wu, Yu Gu, Yong Hu · 2025 · Advanced Functional Materials
- CARG-2020 targets IL-12, IL-17, and PD-L1 pathways to effectively treat melanoma and breast cancerElham Ahmadi, Conner C. Chiari, Bhaskara Reddy Madina, Timur Olegovich Yarovinsky, Marie Marthe Krady, Ju Chen, Bijan Almassian, Valerian Nakaar, Kepeng Wang · 2025 · Scientific Reports
- Heterogeneity-optimized method for predicting immune checkpoint blockade responseJuan Liang, Qihang Guo, Shan Xiang, Yun Wang, Juntao Li · 2025 · Scientific Reports
- Single-cell RNA sequencing identifies CD8Teff cell activation as a predictive biomarker in triple-negative breast cancer immunotherapyLuhui Mao, Zebang Zhang, Yongjian Chen, Qing Peng, Zhenjun Huang, Wenhao Ouyang, Dongqiang Zeng, Wei Ren, Zifan He, Li Tang et al. · 2025 · Molecular Biomedicine
- The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigationsSeiji Mabuchi, Naoko Komura, Harumi Nakamura, Michihide Maeda, Takeshi Yokoi, Shinsuke Koyama, Tomoko Ueda · 2025 · Journal of Gynecologic Oncology
- A clinically relevant pan-cancer prognostic signature derived from T-cell activation immune genes: Experimental validation across malignancies with emphasis on breast cancerJianing Zhang, Xirui Zhou, Yu-tong Wang, Zi-Lu Yi, Linwei Li, Hong Liu · 2025 · Pharmacological Research
- Dual-pathway nanoengineering: spatiotemporal control of immunogenic apoptosis and macrophage phenotype reprogramming for augmented antitumor immunityYunfeng Tang, Xiangtian Deng, Min Yi, Dong Wang, Cheng Zheng, Shichang Zhao, Renliang Zhao · 2025 · Journal of Nanobiotechnology
- Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapyTingting Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Ying Liu, Chunhui Wu · 2026 · BMEMat
- Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogrammingWentao Dong, Yang Li, Zhuolin Wu, Quanlin Fu, Jinshuang Zhao, Bangyue Wang, Jia Yao, Chenglu Lu, Minfeng Tong · 2026 · Frontiers in Immunology
- Piezobiomimetic delivery nanosystem converts cold tumors to hot by parallel PANoptosis/STING activation in hepatocellular carcinomaE Jiaoting, Yuxuan Zhao, Xiaoling Zhang, Q J Zhang, Ying Xu, Shanshan Liu, He Ding, Jiuxin Zhu, Piaoping Yang, Rui Xie · 2026 · Science Advances
- Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challengesNingping Xiao, Chao Chen, Xiuyu Yang, Jiajia Hao, Mian Xie, Jiangtao Wang, Jiayu Xiang, Chang Liu, Xiulin Jiang, Siwei Huang et al. · 2026 · Frontiers in Immunology
- Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer PatientsYushi Nagaki, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Hiromu Fujita, Kohei Kemuriyama, Ryohei Sasamori, Shu Nozaki, Kyoko Nomura, Yoshihiro Minamiya · 2024 · Annals of Surgery Open
- Bioinformatic-Experimental Screening Uncovers Multiple Targets for Increase of MHC-I Expression through Activating the Interferon Response in Breast CancerXin Li, Zi-Lun Ruan, Shuzhen Yang, Qing Yang, Jinpeng Li, Ming‐Ming Hu · 2024 · International Journal of Molecular Sciences
- Ultrasound-guided percutaneous radiofrequency ablation combined with anti-PD-1 for the treatment of prostate cancer: an experimental studySi Chen, Ruiqing Liu, Shaobo Duan, Beibei Zhang, Yuzhou Wang, Xiaoxiao Li, Yingying Zhao, Zesheng Li, Qi Zhou, Rui Zhang et al. · 2025 · Frontiers in Oncology
- A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growthM. Del Río, Oscar-Mariano Nuero-Garcia, Giovanna Roncador, Raquel Garcimartín-Bailon, Juan-Carlos Cubria, Pascal Schneider, J. Rodriguez-Barbosa · 2024 · bioRxiv
- Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1Borui Tang, Yuting Wang, Liping Li, Cuicui Sun, Jingwen Dong, Ruoqi Li, Jianfeng Wang, Yu Long, Mingxiao Yin, Fei Xie et al. · 2025 · Research
- CD80-Mediated T-Cell Suppression by Cancer Stem-like Cells in Head and Neck Squamous Cell CarcinomaMian Xiao, Lin Qiu, Qian Gao, Ruifeng Li, Jing Wang, Yanrui Feng, Xuefen Li, Xi‐Yuan Ge · 2026 · Cells
- HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro explorationMatilde Tubertini, Luca Menilli, Celeste Milani, Cecilia Martini, Maria Luisa Navacchia, Marta Nugnes, Manuela Bartolini, Marina Naldi, Daniele Tedesco, Elisa Martella et al. · 2024 · Frontiers in Chemistry
- HSA-hijacking nanobinders built on bioresponsive prodrugs for combined cancer chemoimmunotherapyMatilde Tubertini, Luca Menilli, Celeste Milani, Cecilia Martini, Maria Luisa Navacchia, Marta Nugnes, Manuela Bartolini, Marina Naldi, Daniele Tedesco, Elisa Martella et al. · 2023 · ChemRxiv
- Organ specific microenvironmental MR1 expression in cutaneous melanomaPatricia B. Gordon, Woong Young So, Udochi F. Azubuike, Bailey Johnson, James Cicala, Victoria E. Sturgess, Claudia Wong, Kevin S. Bishop, Erica Bresciani, Raman B. Sood et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
- Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching AnalysisKegui Weng, Hai-ke Lei, De-Song Shen, Ying Wang, Xiaodong Zhu · 2024 · Cancer Management and Research
- Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinomaZhen Yuan, Huimei Zhou, Dongyan Cao, Jiaxin Yang, Qian Liu · 2024 · Journal of Gynecologic Oncology
- Tumor Cells‐Derived FGF ‐2 Promotes Lymphangiogenesis as a Prognostic Marker in OSCCJia Kang, Aoming Cheng, Guanzheng Chen, Lin Zhu, Zhengxue Han, Qiaoshi Xu · 2025 · Journal of Oral Pathology and Medicine
- Immune-activating cationic lipo-polypeptides for oncolytic immunotherapy in triple negative breast cancerZiwen Gao, Peng Zhang, Renyong Yin, Junqi Wang, Zhihui Guo, Qi Yao, Guowenlie Gao, Xu‐Feng Huang, Chunsheng Xiao, Yingchao Zhang et al. · 2025 · Science China Materials
- NIR-II-activated photothermal therapy using gold nanotetrapods enhances antigen presentation and immune response in colorectal cancerWeijia Zheng, Ling Bai, Nawen Du, Ningning Zhang, Shoujun Zhu, Jianting Xu, Fei Chen, Hongxin Tao, Zhaozhi Li, Min Li et al. · 2025 · Nano Research
- Senescence-associated miRNAs predict survival and modulate the tumor immune microenvironment via SPOCK1 targeting in clear cell renal cell carcinomaZheng Song, Lei Zhang, Xiyue Song, Wei Luo · 2025 · Urologic Oncology Seminars and Original Investigations
- Exploring PKMYT1 as a potential marker for colorectal cancer progression through bioinformatics analyses and experimental validationYuqiang Zhang, Yingwei Chang, Yujie Hu, Zhichao Ding, Zhihui Zhang, Yanbei Wei, Lei Liu, Minghao Yang, Wei Chen · 2025 · Scientific Reports
- Next-Generation of Multimode Imaging and Synergistic Therapeutics for Solid TumorsPavithra Kurungottu, A. Sorna Lakshmi, Agnes Sebastian, Aleena Sabu Koshi, Ashwin T. Shaji, S. Karthik, Anushka Balakrishnan, Rajendra Kurapati · 2025 · Springer eBooks
- Mechanism by which CAP regulates the “cold–heat” balance in osteosarcoma model mice: an integrative study of metabolomics, transcriptomics, and network pharmacologyZiming Wang, Shun Zhang, Shipeng Li, Guosheng Zhao, Yuan Zhang, Xiaohong Zhang, Mingwei Sun, Yun Lu, Enfeng Song, Cantao Quan et al. · 2025 · Journal of Translational Medicine
- Protumor Macrophage Polarization Mediated by BMP2/4–ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor InitiationMingchao Wang, Zhihong Song, Hao Yuan, Chang Liu, Wei Wang, Naixue Yang, Keyong Sun, Shanshan Zhang, Xuyang Qin, Jingwei Li et al. · 2025 · Cancer Research
- Overcoming tumour resistance in cancer immunotherapy through predictive and pharmacodynamic biomarkersHeena Kansal, Vishal Chopra, Kranti Garg, Siddharth Sharma · 2025 · Clinical & Translational Oncology